Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism.

Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, Kolenko VM.

Mol Cancer. 2010 Jul 9;9:183. doi: 10.1186/1476-4598-9-183.

2.

Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.

Yano K, Horinaka M, Yoshida T, Yasuda T, Taniguchi H, Goda AE, Wakada M, Yoshikawa S, Nakamura T, Kawauchi A, Miki T, Sakai T.

Int J Oncol. 2011 Feb;38(2):365-74. doi: 10.3892/ijo.2010.874.

PMID:
21165560
5.

Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin.

Spee B, Jonkers MD, Arends B, Rutteman GR, Rothuizen J, Penning LC.

Mol Cancer. 2006 Sep 5;5:34.

6.

Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer.

Dai Y, Qiao L, Chan KW, Yang M, Ye J, Zhang R, Ma J, Zou B, Lam CS, Wang J, Pang R, Tan VP, Lan HY, Wong BC.

Mol Cancer Ther. 2009 Sep;8(9):2762-70. doi: 10.1158/1535-7163.MCT-09-0509.

7.

Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine.

Cao LP, Song JL, Yi XP, Li YX.

Oncol Rep. 2013 Apr;29(4):1659-65. doi: 10.3892/or.2013.2246.

PMID:
23354694
8.

Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.

Qiao L, Dai Y, Gu Q, Chan KW, Zou B, Ma J, Wang J, Lan HY, Wong BC.

Mol Cancer Ther. 2008 Jul;7(7):2203-11. doi: 10.1158/1535-7163.MCT-08-0326.

9.

Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT.

Machuca C, Mendoza-Milla C, Córdova E, Mejía S, Covarrubias L, Ventura J, Zentella A.

BMC Cell Biol. 2006 Feb 21;7:9.

10.

Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.

Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV.

Oncogene. 2001 Nov 29;20(55):7965-75.

11.
12.

Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.

Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, Kuo ML.

J Biol Chem. 2004 Jun 4;279(23):24015-23.

14.

Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactions.

Rosato RR, Almenara JA, Kolla SS, Maggio SC, Coe S, Giménez MS, Dent P, Grant S.

Mol Cancer Ther. 2007 Feb;6(2):692-702.

15.
16.

Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.

Chovolou Y, Wätjen W, Kampkötter A, Kahl R.

Toxicology. 2007 Mar 22;232(1-2):89-98.

PMID:
17223244
17.
18.

Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation.

Leverkus M, Sprick MR, Wachter T, Mengling T, Baumann B, Serfling E, Bröcker EB, Goebeler M, Neumann M, Walczak H.

Mol Cell Biol. 2003 Feb;23(3):777-90.

19.

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.

Seligson DB, Hongo F, Huerta-Yepez S, Mizutani Y, Miki T, Yu H, Horvath S, Chia D, Goodglick L, Bonavida B.

Clin Cancer Res. 2007 Oct 15;13(20):6056-63.

20.

Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.

Jiang C, Yi XP, Shen H, Li YX.

World J Gastroenterol. 2012 Jun 21;18(23):2956-65. doi: 10.3748/wjg.v18.i23.2956.

Items per page

Supplemental Content

Support Center